California 2023-2024 Regular Session

California Senate Bill SB472

Introduced
2/13/23  
Introduced
2/13/23  
Refer
2/22/23  
Report Pass
3/22/23  
Report Pass
3/22/23  
Refer
3/23/23  
Report Pass
4/13/23  
Report Pass
4/13/23  
Refer
4/17/23  
Refer
4/17/23  
Failed
2/1/24  

Caption

Pupil health: opioid overdose reversal medication.

Impact

By requiring public schools to stock naloxone and train personnel in its administration, SB 472 enhances safety measures to protect students from potential opioid overdoses. This legislative requirement places additional responsibilities on schools to ensure they are prepared for medical emergencies. Each school must maintain at least two doses of naloxone and report specific data regarding the use of these medications to state health and educational departments annually, fostering accountability and awareness about opioid overdoses within school environments.

Summary

Senate Bill 472, introduced by Senator Hurtado, focuses on pupil health and addresses the critical issue of opioid overdoses among school-aged children. The bill amends Section 49414.3 of the Education Code and mandates that public schools maintain emergency supplies of naloxone hydrochloride or other approved opioid antagonists. Schools must ensure that trained personnel are available to administer these lifesaving medications during an emergency. This move aligns with recent efforts to combat the opioid epidemic, particularly in educational settings where opioid use and abuse have been on the rise.

Sentiment

The sentiment surrounding SB 472 is generally positive among health advocates and educators who believe the bill is a proactive step in addressing a critical public health crisis. Supporters laud the bill's focus on pupil safety and health, emphasizing the importance of having necessary resources available in educational facilities. Nevertheless, there are concerns regarding the implications of additional responsibilities and potential costs that schools may incur, particularly if the required training and resources are not fully funded by the state.

Contention

Despite its supportive intent, SB 472 entails some contention related to funding and implementation. Critics express concerns about the unfunded mandates that could financially strain school districts. They argue that without adequate state support for the educational and training resources required for effective implementation, the bill may lead to disparities in preparedness among schools. The dialogue around this bill highlights the broader implications of the opioid crisis and the necessity for coordinated efforts between education and health sectors.

Companion Bills

No companion bills found.

Similar Bills

CA AB19

Pupil health: opioid antagonists.

CA AB3271

Pupil health: opioid antagonists.

CA SB234

Opioid antagonists: stadiums, concert venues, and amusement parks.

CA AB915

Pupil health: drug education: opioid overdose training program.

CA AB1915

Pupil health: drug education: opioid overdose training program.

CA AB2998

Opioid overdose reversal medications: pupil administration.

CA AB1037

Public health: substance use disorder.

CA AB381

Licensed facilities: duties.